Haemonetics
Mark Lincal is currently seeking new opportunities in software and information technology leadership roles. Mark has extensive experience in various executive positions, including Vice President of Software Engineering and Chief Strategic Architect at Haemonetics, Director of Research and Development at Boston Scientific, and General Manager & Director of Engineering at Emageon. Mark also worked as the Director of Software Development at Recipio, where they led a team in designing and releasing customer relationship management and intelligence solutions. Prior to that, they served as a Manager at KPMG, where they successfully transformed a boutique software/services firm into a product company and managed a team of developers and QA professionals.
Mark Lincal attended Marquette University from 1991 to 1995, where they obtained a Bachelor of Engineering (BE) degree in Electrical and Computer Engineering.
This person is not in any offices
Haemonetics
7 followers
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare.